Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of a Potent, CNS‐Penetrant Orexin Receptor Antagonist Based on an N,N‐Disubstituted‐1,4‐diazepane Scaffold that Promotes Sleep in Rats
David B. Whitman, Christopher D. Cox, Michael J. Breslin, et al.
ChemMedChem (2009) Vol. 4, Iss. 7, pp. 1069-1074
Closed Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Orexin Receptors: Pharmacology and Therapeutic Opportunities
Thomas E. Scammell, Christopher J. Winrow
The Annual Review of Pharmacology and Toxicology (2011) Vol. 51, Iss. 1, pp. 243-266
Open Access | Times Cited: 350
Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia
Christopher D. Cox, Michael J. Breslin, David B. Whitman, et al.
Journal of Medicinal Chemistry (2010) Vol. 53, Iss. 14, pp. 5320-5332
Closed Access | Times Cited: 348
Promotion of Sleep by Suvorexant—A Novel Dual Orexin Receptor Antagonist
Christopher J. Winrow, Anthony L. Gotter, Christopher D. Cox, et al.
Journal of Neurogenetics (2011) Vol. 25, Iss. 1-2, pp. 52-61
Closed Access | Times Cited: 255
The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases
Chunmei Wang, Qinqin Wang, Bingyuan Ji, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 163
Multiple roles for orexin/hypocretin in addiction
Stephen V. Mahler, Rachel J. Smith, David E. Moorman, et al.
Progress in brain research (2012), pp. 79-121
Open Access | Times Cited: 211
Direct amidation of azoles with formamides via metal-free C–H activation in the presence of tert-butyl perbenzoate
Tao He, Hongji Li, Pinhua Li, et al.
Chemical Communications (2011) Vol. 47, Iss. 31, pp. 8946-8946
Closed Access | Times Cited: 129
Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia
Christopher J. Winrow, Anthony L. Gotter, Christopher D. Cox, et al.
Neuropharmacology (2011) Vol. 62, Iss. 2, pp. 978-987
Closed Access | Times Cited: 121
Dual Hypocretin Receptor Antagonism Is More Effective for Sleep Promotion than Antagonism of Either Receptor Alone
Stephen R. Morairty, Florent G. Revel, Pari Malherbe, et al.
PLoS ONE (2012) Vol. 7, Iss. 7, pp. e39131-e39131
Open Access | Times Cited: 117
Discovery of [(2R,5R)‐5‐{[(5‐Fluoropyridin‐2‐yl)oxy]methyl}‐2‐methylpiperidin‐1‐yl][5‐methyl‐2‐(pyrimidin‐2‐yl)phenyl]methanone (MK‐6096): A Dual Orexin Receptor Antagonist with Potent Sleep‐Promoting Properties
Paul J. Coleman, John D. Schreier, Christopher D. Cox, et al.
ChemMedChem (2012) Vol. 7, Iss. 3, pp. 415-424
Closed Access | Times Cited: 115
The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia
Paul J. Coleman, Anthony L. Gotter, W. Joseph Herring, et al.
The Annual Review of Pharmacology and Toxicology (2016) Vol. 57, Iss. 1, pp. 509-533
Closed Access | Times Cited: 113
Methyl-containing pharmaceuticals: Methylation in drug design
Shaoyi Sun, Jianmin Fu
Bioorganic & Medicinal Chemistry Letters (2018) Vol. 28, Iss. 20, pp. 3283-3289
Closed Access | Times Cited: 110
Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia
Anthony J. Roecker, Christopher D. Cox, Paul J. Coleman
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 2, pp. 504-530
Closed Access | Times Cited: 107
Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
Orexin receptors as therapeutic drug targets
Anthony L. Gotter, Anthony J. Roecker, Richard Hargreaves, et al.
Progress in brain research (2012), pp. 163-188
Closed Access | Times Cited: 95
Orexin Receptor Antagonists Differ from Standard Sleep Drugs by Promoting Sleep at Doses That Do Not Disrupt Cognition
Jason M. Uslaner, Spencer J. Tye, Donnie Eddins, et al.
Science Translational Medicine (2013) Vol. 5, Iss. 179
Closed Access | Times Cited: 86
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
Jiann Wei Yeoh, Erin J. Campbell, Morgan H. James, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 86
Convergent Kilogram-Scale Synthesis of Dual Orexin Receptor Antagonist
Mélina Girardin, Stéphane G. Ouellet, Danny Gauvreau, et al.
Organic Process Research & Development (2012) Vol. 17, Iss. 1, pp. 61-68
Closed Access | Times Cited: 75
Synthesis of substituted 2-aminobenzoxazoles via copper-catalyzed intramolecular N-arylation of iodophenol and amine-trichloroacetonitrile adduct under ultrasound-irradiation
Manijeh Nematpour
Tetrahedron (2024) Vol. 163, pp. 134145-134145
Closed Access | Times Cited: 6
Understanding the Sleep-Wake Cycle: Sleep, Insomnia, and the Orexin System
Andrew D. Krystal, Ruth M. Benca, Thomas S. Kilduff
The Journal of Clinical Psychiatry (2013) Vol. 74, Iss. suppl 1, pp. 3-20
Open Access | Times Cited: 66
Oxazole and Isoxazole-containing Pharmaceuticals: Targets, Pharmacological Activities, and Their SAR Studies
Shanshan Li, Yujiang Mei, Luchen Jiang, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Orexin Receptor Antagonists: A New Concept In CNS Disorders?
John Gatfield, Catherine Brisbare‐Roch, François Jenck, et al.
ChemMedChem (2010) Vol. 5, Iss. 8, pp. 1197-1214
Closed Access | Times Cited: 65
Orexin receptor antagonists: a review of promising compounds patented since 2006
Paul J. Coleman, John J. Renger
Expert Opinion on Therapeutic Patents (2010) Vol. 20, Iss. 3, pp. 307-324
Closed Access | Times Cited: 60
Optogenetic deconstruction of sleep-wake circuitry in the brain
Antoine Adamantidis
Frontiers in Molecular Neuroscience (2010) Vol. 2
Open Access | Times Cited: 54
Neuropeptides Controlling Energy Balance: Orexins and Neuromedins
Joshua P. Nixon, Catherine M. Kotz, Colleen M. Novak, et al.
Handbook of experimental pharmacology (2011), pp. 77-109
Open Access | Times Cited: 52
Conformational analysis of N,N-disubstituted-1,4-diazepane orexin receptor antagonists and implications for receptor binding
Christopher D. Cox, Georgia B. McGaughey, Michael J. Bogusky, et al.
Bioorganic & Medicinal Chemistry Letters (2009) Vol. 19, Iss. 11, pp. 2997-3001
Closed Access | Times Cited: 55
Page 1 - Next Page

Scroll to top